In addition, the expression of two tumor-suppressor genes—IL-24 and GADD45A—was upregulated in E2-treated PDXs, as well as in organoids that were isolated from E2-treated tumors, depending on treatment time (Figure 2f,g). The gene discussed is GADD45A; the disease is neoplasm.